Orygen Youth Health Research Centre
Parkville, Victoria, 3052, Australia
NCT Number: NCT01399502
The purpose of this study is to investigate the effectiveness of health promotion emails for depression. It is hypothesised that emails containing self-help advice will improve depression symptoms more than emails containing information about depression.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1 / Phase 2
Parkville, Victoria, 3052, Australia
Depression symptoms are commonly experienced and disrupt day-to-day life. Increasing depression literacy and the use of effective self-help methods could improve depression across the community. The internet is an ideal promotional medium for health messages, because it is often used to search for information about mental health issues, and health messages can be widely disseminated at little cost. An email campaign could be a low-cost approach to improving self-help behavior and knowledge about depression in adults with depression symptoms.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive 12 emails over 6 weeks.
Time frame: 6-weeks post baseline
Time frame: 6-months post end-of-intervention
Time frame: 6-weeks post baseline
Time frame: 6-weeks post baseline
Time frame: 6-months post end-of-intervention
Time frame: 6-months post end-of-intervention
Orygen
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06502483
Anxiety, Anxiety Disorders
Brighton, Massachusetts, United States
View Trial DetailsNCT06934135
Anxiety Disorders, Behavior
Lima, Peru
View Trial DetailsNCT03674138
Anxiety, Anxiety Disorders
Tampa, Florida, United States
View Trial DetailsNCT04990401
Behavior, Behavioral Symptoms
Dallas, Texas, United States
View Trial Details